Paediatric autoimmune diseases with ELANE mutations associated with neutropenia

Dan Zhang1, Gaixiu Su2, Sheng Hao3

  • 1Department of Rheumatology and Immunology, Capital Institute of Pediatrics, 2 Yabao Road, Chaoyang District, Beijing, China.

Insights

Children with ELANE mutations can develop autoimmune diseases and recurrent infections. Treatments like DMARDs and stem cell transplantation show promise for managing these conditions.

Area of Science:

  • Pediatric autoimmune diseases
  • Genetics of immune disorders
  • Neutrophil biology

Background:

  • ELANE gene mutations are linked to congenital neutropenia.
  • Autoimmune manifestations in ELANE mutation patients are not well-characterized.
  • Understanding these associations is crucial for diagnosis and treatment.

Purpose of the Study:

  • To investigate the clinical features of autoimmune diseases in pediatric patients with ELANE mutations.
  • To analyze treatment outcomes for these complex cases.

Main Methods:

  • Retrospective analysis of three pediatric cases with ELANE mutations and autoimmune diseases.
  • Review of clinical presentations, genetic testing, and treatment regimens.

Main Results:

  • All three patients presented with recurrent infections.
  • Manifestations included cyclic neutropenia, systemic lupus erythematosus, autoimmune hemolytic anemia, and ANCA-associated vasculitis.
  • Successful treatments involved disease-modifying antirheumatic drugs, allogeneic hematopoietic stem cell transplantation, and granulocyte colony-stimulating factor.

Conclusions:

  • ELANE mutations can predispose children to autoimmune diseases and recurrent infections.
  • Disease-modifying antirheumatic drugs are effective for associated autoimmune conditions.
  • Allogeneic hematopoietic stem cell transplantation offers a potential cure for autoimmune diseases in ELANE-associated neutropenia.
Abstract